STATE STREET CORP - MENLO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MENLO THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$2,529,000
+38.2%
1,461,787
+114.1%
0.00%
Q1 2020$1,830,000
+50.7%
682,718
+160.9%
0.00%
Q4 2019$1,214,000
+12.6%
261,724
+8.8%
0.00%
Q3 2019$1,078,000
-13.7%
240,520
+15.3%
0.00%
Q2 2019$1,249,000
+20.0%
208,522
+57.3%
0.00%
Q1 2019$1,041,000
+37.7%
132,572
-27.7%
0.00%
Q4 2018$756,000
-43.4%
183,421
+35.5%
0.00%
Q3 2018$1,336,000
+76.0%
135,407
+44.6%
0.00%
Q2 2018$759,000
-77.0%
93,638
+6.5%
0.00%
Q1 2018$3,305,00087,9170.00%
Other shareholders
MENLO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DSC Advisors, L.P. 4,359,030$7,541,0008.27%
Healthcare Value Capital, LLC 1,700,000$2,941,0007.51%
683 Capital Management, LLC 5,550,208$9,602,0000.77%
Perceptive Advisors 22,876,410$39,576,0000.64%
Vivo Capital, LLC 3,643,824$6,304,0000.45%
Monashee Investment Management LLC 1,005,000$1,739,0000.26%
MYDA Advisors LLC 93,300$161,0000.10%
Sofinnova Investments, Inc. 725,571$1,256,0000.08%
CAAS CAPITAL MANAGEMENT LP 1,185,501$2,051,0000.07%
Grace Capital 36,012$62,0000.05%
View complete list of MENLO THERAPEUTICS INC shareholders